Archived Newsletters
-
05.10.22 -- Solving Unique Challenges In Pediatric Medicine With Specialized Dosage Forms
5/10/2022
05/10/22 Outsourced Pharma Newsletter
-
05.09.22 -- Can End-To-End CDMO Partnerships Solve Drug Development And Manufacturing Upheaval?
5/9/2022
05/09/22 Outsourced Pharma Newsletter
-
05.09.22 -- 5 Ways For Emerging Biotechs To Launch Smarter
5/9/2022
05/09/22 Outsourced Pharma Newsletter
-
05.07.22 -- The Commercial Manufacturing Journey For A Biologic
5/7/2022
05/07/22 Outsourced Pharma Newsletter
-
05.05.22 -- mRNA Manufacturing Strategies
5/5/2022
05/05/22 Outsourced Pharma Newsletter
-
05.04.22 -- New Episodes: Allogeneic CAR-T Therapies, Antibodies for Severe Allergies, and more.
5/4/2022
05/04/22 Outsourced Pharma Newsletter
-
05.04.22 -- Halozyme's Outsourcing Tip: The External Manufacturing Site Lead
5/4/2022
05/04/22 Outsourced Pharma Newsletter
-
05.03.22 -- Accelerating Development Using Solid Form Screening And Rapid Formulation Selection
5/3/2022
05/03/22 Outsourced Pharma Newsletter
-
05.02.22 -- Exploring Drug And Dose Development
5/2/2022
05/02/22 Outsourced Pharma Newsletter
-
05.02.22 -- FDA Guidance On Voluntary Recalls
5/2/2022
05/02/22 Outsourced Pharma Newsletter
This website uses cookies to ensure you get the best experience on our website. Learn more